CervoMed is a public, Boston, MA-based company advancing CNS-focused therapeutics to benefit patients with neurodegenerative diseases. CervoMed was launched in 2014 as EIP Pharma, Inc, by R&D executives from the pharmaceutical and biotech industry.
In August, 2023 EIP Pharma merged with Diffusion Pharmaceuticals, retaining EIP’s development pipeline, but changing their name to CervoMed (CRVO).
For more information about the company and updates, please visit www.cervomed.com/ or follow us on Twitter at @Cervo_Med.
Company Details
- Employees
- 16
- Founded
- -
- Address
- 20 Park Plaza, Boston,massachusetts 02116,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.cervomed.com
- HQ
- Boston, Massachusetts
Cervomed Questions
Cervomed's website is http://www.cervomed.com
Cervomed's LinkedIn profile is https://www.linkedin.com/company/cervomed
Cervomed has
16 employees.
View email and phone details for 16
employees at Cervomed.
Cervomed's industry is
Pharmaceutical Manufacturing
Cervomed's categories are Pharmaceutical Manufacturing
Cervomed's founding year is 2023
